Acute Rejection, T-Cell–Depleting Antibodies, and Cancer After Transplantation

Abstract

Acute rejection requiring T-cell-depleting antibody is a significant risk factor for cancer development in kidney transplant recipients independent of competing events such as age and cardiovascular deaths.